Divalproex sodium dosage forms and strengths

Revision as of 03:03, 7 February 2014 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Divalproex sodium
DEPAKOTE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Divalproex sodium
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosage Forms And Strengths

Depakote tablets (divalproex sodium delayed-release tablets) are supplied as:[1]

  • 125 mg salmon pink-colored tablets
  • 250 mg peach-colored tablets
  • 500 mg lavender-colored tablets

References

  1. "DEPAKOTE (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [ABBVIE INC.]".

Adapted from the FDA Package Insert.